<DOC>
	<DOC>NCT02202720</DOC>
	<brief_summary>Describe the Richmond Agitation Sedation Scale (RASS) values corresponding to the values of Minimum alveolar concentration of sevoflurane during sedation of patients in ICU</brief_summary>
	<brief_title>Evaluation of Richmond Agitation Sedation Scale According to Alveolar Concentration of Sevoflurane During a Sedation With Sevoflurane in ICU Patients</brief_title>
	<detailed_description>Prospective clinical study in ICU with sedated ventilated patients with sevoflurane using the MirusÂ® system. Pharmacological study of the concentration-effect relationship by administration at increasing and decreasing concentrations.</detailed_description>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Requiring sedation by sevoflurane in ICU Adult patients Patients covered by french health care system Patients who have given their consent or his family Pregnant or lactating women Sevoflurane anaphylaxia Known or suspected risk of malignant hyperthermia Refusal Protocol Braindamaged patients Hemodynamic conditions not compatible with the use of sevoflurane ARDS patients Minor patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Sevoflurane</keyword>
	<keyword>RASS score</keyword>
	<keyword>Sedation</keyword>
	<keyword>Minimal alveolar concentration (MAC)</keyword>
</DOC>